Nanalysis Announces First Quarter 2025 Conference Call
Rhea-AI Summary
Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF) has scheduled its First Quarter 2025 earnings conference call for Wednesday, May 28th, 2025, at 5:00 PM ET. CEO Sean Krakiwsky and CFO Randall McRae will discuss the financial results for the quarter ended March 31, 2025. Investors can participate by dialing 1-888-510-2154 (domestic) or 437-900-0527 (international), or via webcast.
A dedicated European Q&A session will follow on Thursday, May 29th at 8:30 AM ET. The earnings call webcast will be archived for 90 days on the company's website, and a telephonic replay will be available for seven days using conference ID #00805.
Positive
- None.
Negative
- None.
Hosting Call at 5:00 pm ET on Wednesday, May 28th
European Q&A Session on Thursday, May 29th at 8:30am ET
Investors interested in participating in the live full year call can dial 1-888-510-2154 or 437-900-0527-from abroad. Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/eXAlax953qK on the investor relations section of the Company's website
HERE.
The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID # 00805.
Additionally, the Company will be hosting a Q&A session for it's European investors at 8:30am ET on Thursday, May 29th which can be accessed by the following link: Join the meeting now.
About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz platform, which has the highest usable field on a fully featured benchtop NMR on the market. In early 2025, the Company launched its new 60MHz instrument which is based on the successful 100MHz product line.
The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally.
In 2022 the Company was awarded a five-year,
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-first-quarter-2025-conference-call-302456542.html
SOURCE Nanalysis Scientific Corp.